ÂÜÀòÂÒÂ×

Samarendra Mohanty, currently serving as the Chief Scientific Officer at Nanoscope Therapeutics Inc. and NanoScope Technologies, LLC, is leading the clinical translation of technologies developed in the NanoScope laboratory. Their work focuses on early cancer detection, vision restoration in RP/AMD patients, as well as the development of technologies for pain and cancer control. Mohanty holds a Ph.D. from the Indian Institute of Science (IISc) and an M.Tech from the Indian Institute of Technology, Delhi.